Health Benefits of Octacosanol and Other Long-Chain Aliphatic Fatty Alcohols from Plants

  • Yearul Kabir


Octacosanol, a long-chain aliphatic alcohol, exists mainly in a natural wax product that occurs abundantly in wheat germ oil, rice bran oil, fruits, or leaves of many plants. It is a natural fatty alcohol with a variety of important biological and physiological activities and functions having many health benefits. Several studies that evaluated the efficacy of octacosanol by using policosanol (a natural mixture of primary aliphatic alcohols), of which octacosanol is the major component. Due to high stability and encouraging biological activities of octacosanol, currently it is consumed as health products. In recent times, several commercial nutraceutical supplements containing octacosanol have become increasingly popular for health management. This chapter will discuss the role of octacosanol and policosanol in the regulation of lipid metabolism and elaborate its antifatigue, ergogenic, and anti-inflammatory properties; neurological, antioxidant, and antiangiogenic activities; cytoprotective function; and anti-stress activity. The chapter will allow to understand octacosanol’s promotion of energy metabolism, improvement of athletic performance, lowering effects of cholesterol, reduction of platelet aggregation, reduction of risk of ulcer, protective effects on parkinsonism, and so on. The proposed mechanisms behind the functionalities of octacosanol and potential health claims and promotion of optimal health will also be explained. Besides octacosanol, health benefits of other long-chain fatty alcohols will also be included in this chapter. The chapter will enable a better understanding of the current knowledge on potential health benefits of octacosanol and policosanol on human health.


Octacosanol Policosanol Sugar cane wax Lipid lowering Hypocholesterolaemia Therapeutic properties 


  1. Abdul MIM, Jiang X, Williams KM, Day RO, Roufogalis BD, Liauw WS, Xu H, Matthias A, Lehmann RP, McLachlan AJ. Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects. Br J Clin Pharmacol. 2010;69(5):508–15.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Aleman CL, Mas R, Hernandez C, Rodeiro I, Cerejido E, Noa M, Capote A, Menendez R, Amor A, Fraga V, Sotolongo V, Jimenez S. A 12-month study of policosanol oral toxicity in Sprague Dawley rats. Toxicol Lett. 1994a;70(1):77–87.PubMedCrossRefGoogle Scholar
  3. Aleman CL, Mas R, Puig MN, Guerra IR, Ortega CH, Capote A. Carcinogenicity of policosanol in Sprague Dawley rats: a 24 month study. Teratog Carcinog Mutagen. 1994b;14(5):239–49.PubMedCrossRefGoogle Scholar
  4. Aleman CL, Puig MN, Elias EC, Ortega CH, Guerra IR, Ferreiro RM, Brinis F. Carcinogenicity of policosanol in mice: an 18-month study. Food Chem Toxicol. 1995;33:573–8.PubMedCrossRefGoogle Scholar
  5. Arruzazabala ML, Carbajal D, Molina V, Valdes S, Mas R. Effect of policosanol on cerebral ischemia in Mongolian gerbils: role of prostacyclin and thromboxane A2. Prostaglandins Leukot Essent Fatty Acids. 1993;49(3):695–7.PubMedCrossRefGoogle Scholar
  6. Arruzazabala ML, Valdes S, Mas R, Fernandez L, Carbajal D. Effects of policosanol successive dose increases in platelet aggregation in healthy volunteers. Pharmacol Res. 1996;34:181–5.PubMedCrossRefGoogle Scholar
  7. Banerjee S, Ghoshal S, Porter TD. Activation of AMP-kinase by policosanol requires peroxisomal metabolism. Lipids. 2011;46:311–21.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Berthold IG, Berthold HK. Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. Am Heart J. 2002;143:356–65.PubMedCrossRefGoogle Scholar
  9. Berthold HK, Unverdorben S, Degenhardt R, Bulitta M, Gouni-Berthold I. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia – a randomized controlled trial. J Am Med Assoc. 2006;295(19):2262–69.PubMedCrossRefGoogle Scholar
  10. Canetti MM, Moreira M, Mas R, Illnait J, Fernandez L, Fernandez JC. Effects of policosanol on primary hypercholesterolemia: a 3-year open-extension follow-up. Curr Ther Res. 1997;58:868–75.CrossRefGoogle Scholar
  11. Carbajal D, Arruzazabala ML, Valdes S, Mas R. Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers. Prostagl Leukotr Essent Fatty Acids. 1998;58(1):61–4.CrossRefGoogle Scholar
  12. Carling D, Zammit VA, Hardie DG. A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett. 1987;223:217–22.PubMedCrossRefGoogle Scholar
  13. Castano G, Mas R, Feranadez L, Fernandez JC, Illnait J, Lopez LE, Alvarez E. Effects of policosanol on postmenopausal women with type II hypercholesterolemia. Gynecol Endocrinol. 2000;14(3):187–95.PubMedCrossRefGoogle Scholar
  14. Castano G, Mas R, Fernandez JC, Fernandez L, Illnait J, Lopez E. Effects of policosanol on older patients with hypertension and type II hyperlipoproteinaemia. Drugs R D. 2002a;3:159–72.PubMedCrossRefGoogle Scholar
  15. Castano G, Mas R, Fernandez L, Illnait J, Hernández E, Fernandez JC, Gamez R, Gutierrez C, Alvarez E. A randomized, double-blind, placebo-controlled study of the efficacy and tolerability of policosanol in adolescents with type II hypercholesterolemia. Curr Ther Res. 2002b;63(4):286–303.CrossRefGoogle Scholar
  16. Castano G, Arruzazabala ML, Fernandez L, Mas R, Carbajal D, Molina V, Illnait J, Mendoza S, Gamez R, Mesa M, Fernandez J. Effects of combination treatment with policosanol and omega-3 fatty acids on platelet aggregation: A randomized, double-blind clinical study. Curr Ther Res. 2006;67:174–92.PubMedCrossRefGoogle Scholar
  17. Chi HN, Ka YL, Yu H, Zhen YC. Policosanol has no antioxidant activity in human low-density lipoprotein but increase excretion of bile acids in hamsters. J Agr Food Chem. 2005;53:6289–93.CrossRefGoogle Scholar
  18. de Oliveira AM, Conserva LM, de Souza Ferro JN, de Almeida Brito F, Lyra Lemos RP, Barreto E. Antinociceptive and anti-inflammatory effects of octacosanol from the leaves of Sabicea grisea var. grisea in mice. Int J Mol Sci. 2012;13:1598–611.PubMedPubMedCentralCrossRefGoogle Scholar
  19. Fernandez-Arche A, Marquez-Martin A, de la Puerta Vazquez R, Perona JS, Terencio C, Perez-Camino C, Ruiz-Gutierrez V. Long-chain fatty alcohols from pomace olive oil modulate the release of proinflammatory mediators. J Nutr Biochem. 2009;20:155–62.PubMedCrossRefGoogle Scholar
  20. Gamez R, Maz R, Arruzazabala ML, Mendoza S, Castano G. Effects of concurrent therapy with policosanol and omega-3 fatty acids on lipid profile and platelet aggregation in rabbits. Drugs RD. 2005;6(1):11–9.CrossRefGoogle Scholar
  21. Greyling A, De Witt C, Oosthuizen W, Jerling JC. Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects. Br J Nutr. 2006;95(5):968–75.PubMedCrossRefGoogle Scholar
  22. Guardamagna O, Abello F, Baracco V, Stasiowska B, Martino F. The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols. Nutr Metab Cardiovasc Diseases. 2011;21:424–9.PubMedCrossRefGoogle Scholar
  23. Guo YL, Xu RX, Zhu CG, Wu NQ, Cui ZP, Li JJ: Policosanol attenuates statin-induced increases in serum proprotein convertase subtilisin/kexin type 9 when combined with atorvastatin. Evid Based Complement Alternat Med 2014.
  24. Haim D, Valenzuela A, Branes MC, Fuenzalida M, Videla LA. The oleic acid esterification of policosanol increases its bioavailability and hypocholesterolemic action in rats. Grasas Aceites. 2012;63(4):345–54.CrossRefGoogle Scholar
  25. Hernandez F, Illnait J, Mas R, Castano G, Fernandez L, Gonzalez M, Cordovi N, Fernandez J. Effect of policosanol on serum lipids and lipoproteins in healthy volunteers. Curr Ther Res. 1992;51:568–75.Google Scholar
  26. Herrera MN, Magraner J, Mas R. Effect of policosanol on isoprenaline-induced myocardial necrosis in rats. J Pharm Pharmacol. 1994;46:282–5.PubMedCrossRefGoogle Scholar
  27. Illnait J, Lopez E, Fernandez L, Mas R, Gamez R, Mesa M, Mendoza S, Fernandez JC. Effects of policosanol (5 and 10 mg/day) in adults with serum cholesterol levels ≤ 5.9 mmol/L. Int J Pharm Sci Rev Res. 2013;22(2):303–9.Google Scholar
  28. Kabir Y, Kimura S. Biochemical effect of octacosanol on voluntary exercise in rats. Dhaka Univ Studies (Part E). 1991;6:77–85.Google Scholar
  29. Kabir Y, Kimura S. Biodistribution and metabolism of orally administered octacosanol to rats. Ann Nutr Metab. 1993;37:33–8.PubMedCrossRefGoogle Scholar
  30. Kabir Y, Kimura S. Distribution of radioactive octacosanol in response to exercise in rats. Nahrung. 1994;4:373–7.CrossRefGoogle Scholar
  31. Kabir Y, Kimura S. Tissue distribution of (8-14C)-octacosanol in liver and muscle of rats after serial administration. Ann Nutr Metab. 1995a;39:279–84.PubMedCrossRefGoogle Scholar
  32. Kabir Y, Kimura S. Metabolism of octacosanol in liver and muscle of rat. Acta Aliment. 1995b;24:39–46.Google Scholar
  33. Kassis AN, Jones PJH. Changes in cholesterol kinetics following sugar cane policosanol supplementation: a randomized control trial. Lipids Health Dis. 2008;7:17.PubMedPubMedCentralCrossRefGoogle Scholar
  34. Kaushik MK, Aritake K, Takeuchi A, Yanagisawa M, Urade Y. Octacosanol restores stress affected sleep in mice by alleviating stress. Sci Rep. 2017;7:8892.PubMedPubMedCentralCrossRefGoogle Scholar
  35. Keller S, Gimmler F, Jahreis G. Octacosanol administration to humans decreases neutral sterol and bile acid concentration in feces. Lipids. 2008;43:109–15.PubMedCrossRefGoogle Scholar
  36. Kim H, Park S, Han DS, Park T. Octacosanol supplementation increases running endurance time and improves biochemical parameters after exhaustion in trained rats. J Med Food. 2003;6:345–51.PubMedCrossRefGoogle Scholar
  37. Kim JY, Kim SM, Kim SJ, Lee EY, Kim JR, Cho KH. Consumption of policosanol enhances HDL functionality via CETP inhibition and reduces blood pressure and visceral fat in young and middle-aged subjects. Int J Mol Med. 2017;39:889–99.PubMedPubMedCentralCrossRefGoogle Scholar
  38. Kim S-J, Yadav D, Park H-J, Kim J-R, Cho K-H. Long-term consumption of Cuban policosanol lowers central and brachial blood pressure and improves lipid profile with enhancement of lipoprotein properties in healthy Korean participants. Front Physiol. 2018;9:412.PubMedPubMedCentralCrossRefGoogle Scholar
  39. Kitts DD, Kopec A, Zawistowski J, Popovich DG. Effects of high molecular weight alcohols from sugar cane fed alone or in combination with plant sterols on lipid profile and antioxidant status of Wistar rats. Appl Physiol Nutr Metab. 2012;37(5):938–46.PubMedCrossRefGoogle Scholar
  40. Kubo I, Muroi H, Kubo A. Antibacterial activity of long-chain alcohol against Streptococcus mutans. J Agric Food Chem. 1993;41:2447–50.CrossRefGoogle Scholar
  41. Laguna A, Magraner J, Carbajal D, Arruzazabala ML, Mas R, Garcıa M. A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmacological uses. U.S. Patent 5663156, 1997.Google Scholar
  42. Lee J-Y, Choi H-Y, Kang Y-R, Chang H-B, Chun H-S, Lee M-S, Kwon Y-I. Effects of long-term supplementation of policosanol on blood cholesterol/glucose levels and 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in a rat model fed high cholesterol diets. Food Sci Biotechnol. 2016;25(3):899–904.PubMedPubMedCentralCrossRefGoogle Scholar
  43. Li Q, Thomson AB, Clandinin MT. Cholesterol ester and free fatty acids are modulated by policosanol in CaCo-2 intestinal cell. J Am Coll Nutr. 2011;30:201–9.PubMedCrossRefGoogle Scholar
  44. Liu S, Tan MY, Zhao SP, Rong H. Effects of policosanol on serum lipids and heme oxygenase-1 in patients with hyperlipidemia. Zhonghua Xin Xue Guan Bing Za Zhi. 2012;40:840–3.PubMedGoogle Scholar
  45. Long L, Gao MZ, Peng K, Sun J, Wang SX. Effects of octacosanol extracted from rice bran on production performance and blood parameters in weanling piglets. J Chin Cereals Oils Assoc. 2015;30:94–100. [in Chinese]Google Scholar
  46. Long L, Wu SG, Yuan F, Wang J, Zhang HJ, Qi GH. Effects of dietary octacosanol on growth performance, carcass characteristics and meat quality of broiler chicks. Asian Australas J Anim Sci. 2016;29:1470–6.PubMedPubMedCentralCrossRefGoogle Scholar
  47. Lopez E, Illnait J, Fernandez JC, Fernandez L, Gamez R, Mesa M, Mendoza S, Mas R, Ruiz D, Jardines Y. Effects of sugarcane wax alcohols in subjects with normal or borderline serum cholesterol levels. Rev CENIC Cien Biol. 2010;41:31–7.Google Scholar
  48. Lopez E, Fernandez L, Mas R, Illnait J, Mendoza S, Ramirez Y, Fernández JC, Ruiz ID. A comparison of the long-term (1 year) lipid modifying effects of D-003 (sugarcane wax acids) and policosanol: A randomized, double-blind study. Int J Pharm Sci Rev Res. 2015;33(1):171–8.Google Scholar
  49. Marazzi G, Cacciotti L, Pelliccia F, Iaia L, Volterrani M, Caminiti G, Sposato B, Massaro R, Grieco F, Rosano G. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. Adv Ther. 2011;28(12):1105–13.PubMedCrossRefGoogle Scholar
  50. Marinangeli CP, Kasis AN, Jain D, Ebine N, Gunnane SC, Jones PJ. Comparison of composition and absorption of sugarcane policosanols. Br J Nutr. 2007;97(2):381–8.PubMedCrossRefGoogle Scholar
  51. Martino F, Puddu PE, Pannarale G, Colantoni C, Martino E, Niglio T, Zanoni C, Barillà F. Low dose chromium-polynicotinate or policosanol is effective in hypercholesterolemic children only in combination with glucomannan. Atherosclerosis. 2013;228:198–202.PubMedCrossRefGoogle Scholar
  52. Menendez R, Sotolongo V, Fraga V, Amor AM, Gonzalez R, Del Rio A, Jimenez S, Perez N, Mas R. Plasma levels and total radioactivity excretion in healthy volunteers after oral 3H-octacosanol administration. Rev CENIC Cien Biol. 1996;27:32–5.Google Scholar
  53. Menendez R, Más R, Amor AM, Fernandez JC, Gonzalez RM. Effects of policosanol on the susceptibility of low-density lipoprotein isolated from hypercholesterolemic patients at high coronary risk to in vitro copper-mediated lipid peroxidation: a randomized, double-blind pilot study. Curr Ther Res. 2000a;61(9):609–20.CrossRefGoogle Scholar
  54. Menendez R, Mas R, Amor AM, Gonzalez RM, Fernandez JC, Rodeiro I, Zayas M, Jimenez S. Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro. Br J Clin Pharmacol. 2000b;50(3):255–62.PubMedPubMedCentralCrossRefGoogle Scholar
  55. Menendez R, Amor A, Rodeiro I, Gonzalez RM, Gonzalez PC, Alfonso JL, Mas R. Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts. Arch Med Res. 2001;32(1):8–12.PubMedCrossRefGoogle Scholar
  56. Menendez R, Marrero D, Mas R, Fernandez I, Gonzalez L, Gonzalez RM. In vitro and in vivo study of octacosanol metabolism. Arch Med Res. 2005;36(2):113–9.PubMedCrossRefGoogle Scholar
  57. Mesa AR, Mas R, Noa M, Hernandez C, Rodeiro I, Gamez R, Garcia M, Capote A, Aleman CL. Toxicity of policosanol in beagle dogs: one-year study. Toxicol Lett. 1994;73(2):81–90.PubMedCrossRefGoogle Scholar
  58. Molina V, Carbajal D, Arruzazabala ML, Ravelo Y, Mas R. Comparative study of policosanol and grape seed extract on platelet aggregation in rats. Rev CENIC Cienc Biol. 2011;42(1):3–6.Google Scholar
  59. Molina V, Ravelo Y, Noa M, Mas R, Perez Y, Oyarzabal A, Mendoza N, Valle M, Jimenez S, Sánchez J. Therapeutic effects of policosanol and atorvastatin against global brain ischaemia-reperfusion injury in Gerbils. Indian J Pharm Sci. 2013;75(6):635–41.PubMedPubMedCentralGoogle Scholar
  60. Molina V, Ravelo Y, Mena L, Noa M, Perez Y, Oyarzaba A, Valle M, Jimenez S. Therapeutic effects of policosanol and omega-3 fish oil against global brain ischemia reperfusion in Mongolian gerbils. Int J Pharm Sci Rev Res. 2017;42(2):179–85.Google Scholar
  61. Murphy KJ, Saint DA, Howe PR. Lack of effect of sugarcane and sunflower seed policosanols on plasma cholesterol in rabbits. J Am Coll Nutr. 2008;27:476–84.PubMedCrossRefGoogle Scholar
  62. Noa M, Herrera M, Magraner J, Mas R. Effect of policosanol on isoprenaline-induced myocardial necrosis in rats. J Pharm Pharmacol. 1994;46:282–5.PubMedCrossRefGoogle Scholar
  63. Noa M, Mendoza S, Más R, Mendoza N. Effect of policosanol on carbon tetrachloride-induced acute liver damage in Sprague-Dawley rats. Drugs Res Develop. 2003;4:29–35.Google Scholar
  64. Norris FH, Denys EH, Fallat RJ. Trial of octacosanol on amyotrophic lateral sclerosis. Neurology. 1986;36(9):1263–4.PubMedCrossRefGoogle Scholar
  65. Ohashi K, Ishikawa H, Ohta Y. Octacosanol ameliorates hyperlipidemia and oxidative stress in KKAy mice with type 2 diabetes. J Anal Bio Science. 2011;34(3):223–33.Google Scholar
  66. Ohta Y, Sasaki E, Ishiguro I. Effect of oral octacosanol administration on hepatic triglyceride accumulation in rats with carbon tetrachloride-induced acute liver injury. Med Biol. 1997;134:185–9.Google Scholar
  67. Ohta Y, Ohashi K, Matsura T, Tokunaga K, Kitagawa A, Yamada K. Octacosanol attenuates disrupted hepatic reactive oxygen species metabolism associated with acute liver injury progression in rats intoxicated with carbon tetrachloride. J Clin Biochem Nutr. 2008;42:118–25.PubMedPubMedCentralCrossRefGoogle Scholar
  68. Oliaro-Bosso S, Calcio E, Mantegna S, Giraudo E, Meda C, Viola F, Cravotto G. Regulation of HMG-CoA reductase activity by policosanol and octacosadienol, a new synthetic analogue of octacosanol. Lipids. 2009;44(10):907–16.PubMedCrossRefGoogle Scholar
  69. Perez Y, Mas R, Oyarzabal A, Jimenez S, Molina V. Effects of policosanol (sugar cane wax alcohols) and D-003 (sugarcane wax acids) on cyclooxygenase (COX) enzyme activity in vitro. Int J Pharm Sci Rev Res. 2013;19(2):18–23.Google Scholar
  70. Perez Y, Mas R, Oyarzábal A, Jimenez S, Molina V. Effects of octacosanol and triacontanol alcohols on cyclooxygenase and 5-lipoxygenase enzyme activities in vitro. Rev Cubana Farm. 2015a;49(1):117–31.Google Scholar
  71. Perez Y, Molina V, Mas R, Oyarzabal A, Jiménez S. Effects of policosanol pre-treatment on blood-brain barrier damage induced by ischemia-reperfusion in rats. Int J Pharm Sci Rev Res. 2015b;32(1):1–6.Google Scholar
  72. Pons P, Rodriguez M, Mas R, Illnait J, Fernandez L, Robaina C, Fernandez JC. One-year efficacy and safety of policosanol in patients with type II hypercholesterolaemia. Curr Ther Res. 1994;55(9):1084–92.CrossRefGoogle Scholar
  73. Reiner Z, Tedeschi-Reiner E, Romic Z. Effects of rice policosanol on serum lipoproteins, homocysteine, fibrinogen and C-reactive protein in hypercholesterolaemic patients. Clin Drug Invest. 2005;25(11):701–7.CrossRefGoogle Scholar
  74. Rodriguez MD, Garcia H. Teratogenic and reproductive studies of policosanol in the rat and rabbit. Teratog Carcinog Mutagen. 1994;14(3):107–13.PubMedCrossRefGoogle Scholar
  75. Rodriguez MD, Garcia H. Evaluation of peri- and post-natal toxicity of policosanol in rats. Teratog Carcinog Mutagen. 1998;18(1):1–7.PubMedCrossRefGoogle Scholar
  76. Rodriguez I, Illnait J, Molina V, Oyarzábal A, Fernándezl MM, Mas R, Mendoza S, Gamez R, Jiménez S, Ruiz D. Comparison of the antioxidant effects of D-002 (beeswax alcohols) and grape seed extract (GSE) on plasma oxidative variables in healthy subjects. Lat Am J Pharm. 2010;29:255–62.Google Scholar
  77. Rodriguez MD, Sanchez M, Garcia H. Multigeneration reproduction study of policosanol in rats. Toxicol Lett. 1997;90:97–106.PubMedCrossRefGoogle Scholar
  78. Rodríguez-Echenique C, Mesa R, Mas R, Noa M, Menendez R, Gonzalez RM, Amor AM, Fraga V, Sotolongo V, Laguna A. Effect of policosanol chronically administered in male monkeys (Macacaarctoides). Food Chem Toxicol. 1994;32(6):565–75.PubMedCrossRefGoogle Scholar
  79. Rozza F, de Simone G, Izzo R, De Luca N, Trimarco B. Nutraceuticals for treatment of high blood pressure values in patients with metabolic syndrome. High Blood Press Cardiovasc Prev. 2009;16(4):177–82.PubMedCrossRefGoogle Scholar
  80. Saint-John M, McNaughton L. Octacosanol ingestion and its effects on metabolic responses to submaximal cycle ergometry, reaction time and chest and grip strength. Int Clin Nutr Rev. 1986;6:81–7.Google Scholar
  81. Saito M, Kinoshita Y, Satoh I, Shinbori C, Kono T, Hanada T, Uemasu J, Suzuki H, Yamada M, Satoh K. n-hexacosanol ameliorates streptozotocin-induced diabetic rat nephropathy. Eur J Pharmacol. 2006;544:132–7.PubMedCrossRefGoogle Scholar
  82. Sanchez J, Mas R, Mendoza S, Fernandez J, Ruiz D. Effects of policosanol on patients with ischemic stroke with previous transient ischemic attack: a long-term follow-up. Rev CENIC Cien Biol. 2010;41:23–9.Google Scholar
  83. Sanchez J, Fernandez L, Illnait J, Arruzazabala ML, Molina V, Mas R. Effects of policosanol on the recovery of ischemic stroke: a randomized controlled study. IOSR J Pharm. 2012;2(6):14–24.Google Scholar
  84. Sanchez J, Illnait J, Mas R, Perez Y, Mendoza S, Cabrera L, Fernandez L, Mesa M, Fernandez J, Oyarzabal A, Molina V, Jimenez S, Reyes P. Effects of policosanol plus aspirin therapy on the neurological recovery and plasma oxidative markers of patients with ischemic stroke. IOSR J Pharm. 2013;3(4):31–40.Google Scholar
  85. Sanchez J, Illnait J, Mas R, Mendoza S, Vega H, Fernandez L, Mesa BM, Fernandez J, Reyes P, Ruiz D. Policosanol versus atorvastatin on the functional recovery of patients with ischemic stroke. Int J Pharm Sci Rev Res. 2016;37(1):7–14.Google Scholar
  86. Sengupta S, Nandi I, Bhattacharyya DK, Ghosh M. Anti-oxidant and anti-bacterial properties of 1-octacosanol isolated from rice bran wax. J Plant Biochem Physiol. 2018;6:1.
  87. Shimura S, Hasegawa T, Takano S, Suzuki T. Studies on the effect of octacosanol on motor endurance in mice. Nutr Rep Int. 1987;36:1029–38.Google Scholar
  88. Singh DK, Li L, Porter TD. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase. J Pharmacol Exp Ther. 2006;318(3):1020–6.PubMedCrossRefGoogle Scholar
  89. Swanson B, Keithley JK, Sha BE, Fogg L, Nerad J, Novak RM, Adeyemi O, Spear GT. Policosanol for managing human immunodeficiency virus–related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial. Altern Ther Health Med. 2011;17(2):30–35.Google Scholar
  90. Tanaka Y, Fukuda S, Kikuzaki H, Nakatani N. Antibacterial activity of aliphatic long-chain compounds against upper-airway respiratory tract pathogens. ITE Lett Batter New Technol Med. 2002;1:777–80.Google Scholar
  91. Tedeschi-Reiner E, Reiner Z, Romic Z, Ivankovic D. A randomized, double blind, placebo-controlled study of the antilipemic efficacy and tolerability of food supplement policosanol in patients with moderate hypercholesterolemia. Lijec Vjesn. 2005;127:273–9.PubMedGoogle Scholar
  92. Thippeswamy G, Sheela MI, Salimath BP. Octacosanol isolated from Tinospora cordifolia downregulates VEGF gene expression by inhibiting nuclear translocation of NF-kappaNB and its DNA binding activity. Eur J Pharmacol. 2008;588:141–50.PubMedCrossRefGoogle Scholar
  93. Togashi N, Shiraishi A, Nishizaka M, Matsuoka K, Endo K, Hamashima H, Inoue Y. Antibacterial activity of long-chain fatty alcohols against Staphylococcus aureus. Molecules. 2007;12(2):139–48.PubMedPubMedCentralCrossRefGoogle Scholar
  94. Viola F, Oliaro S, Binello A, Cravotto G. Policosanol: updating and perspectives. Mediterr J Nutr Metab. 2008;1:77–83.CrossRefGoogle Scholar
  95. Wang YW, Jones PJH, Pischel I, Fairow C. Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters. Lipids. 2003;38(2):165–70.PubMedCrossRefGoogle Scholar
  96. Wang T, Liu YY, Wang X, Yang N, Zhu HB, Zuo PP. Protective effects of octacosanol on 6-hydroxydopamine-induced Parkinsonism in rats via regulation of ProNGF and NGF signaling. Acta Pharmacol Sin. 2010;31:765–74.PubMedPubMedCentralCrossRefGoogle Scholar
  97. Wang T, Liu Y, Yang N, Ji C, Chan P, Zuo P. Anti-parkinsonian effects of octacosanol in 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine-treated mice. Neural Regen Res. 2012;7(14):1080–7.PubMedPubMedCentralGoogle Scholar
  98. Wong W-T, Ismail M, Tohit ERM, Abdullah R, Zhang Y-D. Attenuation of thrombosis by crude rice (Oryza sativa) bran policosanol extract: Ex vivo platelet aggregation and serum levels of arachidonic acid metabolites. Evidence Based Compl Altern Med. 2016;2016:8. Article ID 7343942Google Scholar
  99. Xu ZY, Fitz E, Riediger N, Moghadasian MH. Dietary octacosanol reduces plasma triacylglycerol levels but not atherogenesis in apolipoprotein E-knockout mice. Nutr Res. 2007;27:212–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Yearul Kabir
    • 1
  1. 1.Department of Biochemistry and Molecular BiologyUniversity of DhakaDhakaBangladesh

Personalised recommendations